Formycon AG (CHIX:FYBD) Tax Expense: €-25.80 Mil (TTM As of Dec. 2025)


CHIX:FYBD Formycon AG CHIX:FYBD
56 GF Score
Price €63.30
GF Value €120.94
! 5 Warning Signs
View Full Analysis

What is Formycon AG Tax Expense?

Formycon AG CHIX:FYBD 56 Tax Expense is €-25.80 Mil as of Dec. 2025. GuruFocus rates CHIX:FYBD with a GF Score™ of 56/100 and a GF Value™ of €120.94. The stock has 5 warning signs investors should review.

Formycon AG's tax expense for the months ended in Dec. 2025 was €-25.11 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was €-25.80 Mil.


Formycon AG  (CHIX:FYBd) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Formycon AG Tax Expense Related Terms


Formycon AG Tax Expense Historical Data

* Premium members only.

The historical data trend for Formycon AG's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Formycon AG Tax Expense Chart

Formycon AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.92 0.60 3.28 -18.58 -25.80

Formycon AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.98 2.40 -20.98 -0.69 -25.11
CHIX:FYBD
56GF Score
Formycon AG CHIX:FYBD
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Formycon AG Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-25.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of €-25.80 Mil mean?
Formycon AG (CHIX:FYBD) has a Tax Expense of €-25.80 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Formycon AG and its competitors.
Is Formycon AG's Tax Expense too high?
Formycon AG's current Tax Expense is €-25.80 Mil. Overall, Formycon AG has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Formycon AG's Tax Expense compare to VRTX and REGN?
Formycon AG's Tax Expense of €-25.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Biotechnology company?
A good Tax Expense depends on the Biotechnology industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Formycon AG and its competitors. Formycon AG's current Tax Expense is €-25.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formycon AG stock overvalued right now?
Formycon AG (CHIX:FYBD) has a current Tax Expense of €-25.80 Mil. The stock's GF Value™ is €120.94, compared to a current price of €63.30 — trading 47.7% below its estimated fair value. The current Tax Expense is €-25.80 Mil. Formycon AG's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Formycon AG (CHIX:FYBD), the current Tax Expense is €-25.80 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Formycon AG (CHIX:FYBD) Overvalued in 2026?

Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued. The current stock price of €63.30 is trading 47.7% below its estimated GF Value™ of €120.94.

Key valuation signals for CHIX:FYBD:

  • Tax Expense: €-25.80 Mil
  • GF Value™: €120.94 vs. price of €63.30 (47.7% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the CHIX:FYBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Formycon AG Business Description

Address Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
56GF Score

Get the complete analysis for CHIX:FYBD

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.30
Price
€120.94
GF Value